Skip to main content
. 2011 Nov 30;6(11):e28230. doi: 10.1371/journal.pone.0028230

Figure 1. Myeloperoxidase (MPO)-modified low-density lipoprotein/apolipoprotein B (Mox-LDL/ApoB) ratio (A) and MPO (B) at baseline, and during sleep restriction and recovery periods.

Figure 1

Values are shown as medians (25%–75% range). Baseline (average of the 3 baseline days for each volunteer) was used as control and other days as the comparative groups. Data comparisons with the baseline were performed using a Friedman Repeated Measures Analysis of Variance on Ranks and a Dunn's post-hoc test. * Significant difference vs. baseline (P<0.05).